April 1, 2021
The Global Health Innovative Technology (GHIT) Fund said on March 31 that it will invest a total of around 2.3 billion yen in 10 projects to develop new drugs for malaria, tuberculosis, Chagas disease, and visceral leishmaniasis. Four of these...read more